Second patient dies in France's artificial heart trial

May 4, 2015

The second person in France to receive a much-hyped new-generation artificial heart has died eight months after receiving the transplant, biomedical firm Carmat said Tuesday.

The 69-year-old man, who wished to remain anonymous, was terminally ill when he received the experimental that was seen as a long-term solution for with end-stage .

Carmat, which designed what it calls the world's most-advanced artificial heart, said the patient was admitted to hospital on Friday with "circulatory collapse".

A medical team noted the heart was not functioning correctly and transplanted a new device, however the patient died on Saturday from post-operative complications.

Artificial hearts have been in use for many years as a temporary fix for patients with chronic heart problems.

However Carmat hopes to provide a longer-term solution to tens of thousands who suffer from —the world's leading cause of death—and are unable to receive a transplant.

The device, a self-contained unit implanted in a patient's chest, is a mix of synthetic materials and animal tissue, and seeks to mimic the form and function of an actual .

The artificial heart uses soft biomaterials intended to lessen the risk of blood clots and rejection by the immune system. It is powered by a belt of lithium batteries.

Carmat's first trial of the device on a 76-year-old man ended March 2 with the patient's death after two and a half months.

The second patient said in an interview with French media a month ago that he had "recovered" to the point of going on bike rides.

Nearly 100,000 people in Europe and the United States are in need of a , according to Carmat, but only about 4,000 hearts become available for transplant.

The French firm's trial was to involve four people. A third patient was confirmed to have received their last week.

The first phase of the trial will be considered a success if patients survive for a month after the transplant. Carmat will then carry out a second phase of clinical trials which will involve 20 patients.

Explore further: France's second artificial heart recipient says 'recovered'

Related Stories

France's second artificial heart recipient says 'recovered'

April 5, 2015
A man who in August became the second person in France to receive a much-hyped new-generation artificial heart said in his first interview Sunday he had "recovered", to the point of going on bike rides.

France's second artificial heart recipient 'doing well'

October 28, 2014
A man who in August became the second person in France to receive a new-generation artificial heart "is doing very well," the inventor of the pioneer device said Tuesday.

Trial continues after patient death: French heartmaker

March 4, 2014
French biomedical firm Carmat said Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient died.

Second artificial heart implant due in 'weeks'

March 17, 2014
After its first recipient died, French biomedical firm Carmat said on Monday it expected to try again to implant its experimental artificial heart in another patient "in several weeks".

France announces second artificial heart transplant

September 8, 2014
France last month carried out the second transplant of a new-generation artificial heart, Health Minister Marisol Touraine said Monday.

Man with first artificial heart dies after 75 days

March 3, 2014
A septuagenarian man who was fitted with the French biomedical firm Carmat's first artificial heart two and half months ago has died, a hospital statement said Monday.

Recommended for you

Post-heart attack: How can scar tissue be turned back into healthy heart muscle?

September 26, 2017
Heart disease continues to be the leading cause of death worldwide, partly due to limited therapeutic options and the heart's inability to regenerate healthy cells called cardiomyocytes after heart attacks. Scientists at ...

Genetic testing helps set safe dose of common blood thinner

September 26, 2017
Warfarin is a blood thinner that is commonly prescribed to patients to prevent life-threatening blood clots. Despite its longtime use, warfarin remains tricky to dose because a person's genetic makeup influences how the drug ...

Higher risk of heart failure in cold weather, study suggests

September 26, 2017
An increase in hospitalization and death in elderly patients with heart failure could be associated with changes in temperature and atmospheric pressure, according to a new study in Environment International. The authors ...

Gene therapy improved left ventricular and atrial function in heart failure by up to 25 percent

September 25, 2017
Heart function improved by up to 25 percent in a trial using gene therapy to reverse cardiac damage from congestive heart failure in a large animal model, Mount Sinai researchers report. This is the first study using a novel ...

Tension makes the heart grow stronger

September 25, 2017
By taking videos of a tiny beating zebrafish heart as it reconstructs its covering in a petri dish, scientists have captured unexpected dynamics of cells involved in tissue regeneration. They found that the depleted heart ...

Hospital mortality rates after heart attack differ by age

September 25, 2017
Outcomes for older patients hospitalized for a heart attack are often used as a measure of hospital quality for all patients. But a study led by Yale researchers shows that hospital mortality rates for older patients with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.